A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
Isabella Orienti(University of Bologna), Ann Zeuner(Istituto Superiore di Sanità)
Cited by 57
Related Papers
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer
|Cell Death and Differentiation|2014|113
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2020|85
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
|Cell Death and Differentiation|2015|55
Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem–like Cells to Protect Them from Chemotherapy
|Cancer Research|2013|43
<p>Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an <em>MYCN</em> Amplified Neuroblastoma Tumor</p>
|International Journal of Nanomedicine|2020|8